Drugs / Prophylactic/Intermediate Dose Enoxaparin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04401293 Comparator | Apr 2020 → May 2021 | COVID-19 | Northwell Health | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Prophylactic/Intermediate Dose Enoxaparin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04401293 ↗ |